VERAPAMIL FOLLOWING UNCOMPLICATED MYOCARDIAL-INFARCTION - PROMISING, BUT NOT PROVEN

The available data on the use of verapamil following myocardial infarc tion are summarized, and indicate a potential for reduced reinfarction rates and trends toward lower mortality. These data contrast sharply with the available data on dihydropyridine calcium antagonists which d emonstrate trends toward an increase in both reinfarction and death.